Publication | Open Access
Effectiveness of Molnupiravir in High-Risk Patients: A Propensity Score Matched Analysis
59
Citations
8
References
2022
Year
This study suggests that in the era of Omicron and in real-life setting, molnupiravir might be effective in reducing the risk of severe COVID-19 and COVID-19-related mortality, particularly in specific subgroups.
| Year | Citations | |
|---|---|---|
Page 1
Page 1